Expert insights. Personalized for you.
The article How Has Brexit Affected Pharmaceutical Distribution in the UK? Editorial Brexit pharmaceutical distribution UKThis article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. MORE
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset MORE
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied MORE
213 
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. In fact, if you knew that the business model of PLM was always to package and sell data to researchers, including the pharmaceutical industry, you may shrug your shoulders and assume there is no fundamental change. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. MORE
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. How that demand side will reconcile with the supply side of pharmaceutical and life science companies, health insurers, retail pharmacy, hospitals and physicians — all strong and assertive lobbies inside the Beltway — will become clearer over the next thirteen months. MORE
Behavior change Diabetes Employee benefits Employers Health benefits Health Consumers Health costs Health Economics Health engagement Health insurance Health politics Health reform Healthcare access Heart health HIV/AIDS Hospitals Loneliness Medicaid Medicare Medicines Money and health Personal health finance Pharmaceutical Prescription drugs Public health Seniors and health Social determinants of health Universal health careNational health spending in the U.S. is expected to grow by 5.7% MORE
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health. The driving forces shaping health and health care around the world are re-shaping health care financing and delivery around the world, and especially considering the growing role of patients in self-care — in terms of financing, clinical decision making and care-flows. MORE
Also: Skin Analytics' Series A contributes to AI-based detection of potential skin cancer; China's LickDoc supports its healthcare big data repository with $102 million MORE
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People The Chinese government estimates that spending in its healthcare sector will reach $2.3 MORE
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. Innovation is not a choice but rather a growth mindset, which creates an environment for building a sustainable business. This mindset allows for objectivity and contributions towards a bigger shared purpose. MORE
183 
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin MORE
The platform provides solutions in energy health and safety training and now brings its training expertise to the pharmaceuticals sector MORE
212 The technology has a built-in sensor that can send usage data to a corresponding smartphone app. MORE
212 
Bio/life sciences Business and health Coronavirus COVID-19 Education and health Health benefits Health care industry Health citizenship Health Consumers Health costs Health ecosystem Health insurance Health Plans Health policy Health politics media and health Medical innovation Medicines Money and health Personal health finance Pharmaceutical Pre-existing conditions Prescription drugs Public health SDoH Shared decision making Social determinants of health Universal health care Wellbeing MORE
Chronic care Chronic disease Coronavirus COVID-19 Diabetes Digital health Health at home Health benefits Health care industry Health Consumers Health engagement Health finance Health insurance Health Plans Health policy Heart disease Home care Hospital finance Hospitals medical home Medicare Medication adherence Medicines Mental health Pharmaceutical Pharmacy Prescription drugs Prevention and wellness Primary care Self-care Telehealth Telemedicine Virtual healthPatients in the U.S. MORE
Industry Voices—Pharmaceutical supply chain adjustments to outlast COVID-19. hlandi. Mon, 09/14/2020 - 13:43 MORE
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Artificial intelligence Big data and health Bio/life sciences Biotech Data analytics and health Health care industry Health ecosystem Health insurance Medicare Medicines Personalized medicine Pharmaceutical Venture capital and health MORE
Bio/life sciences Financial toxicity Health Consumers Health costs Health policy Health politics media and health Medicaid Medicare Medicines Pharmaceutical Pharmacy Prescription drugs Retail health Specialty drugs Transparency Women and healthNine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today. MORE
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. citizens together is agreement that the cost of health care is too high in the country, and that pharma, health plans, and providers are to blame. MORE
The CARE consortium will accelerate R&D by bringing together expertise from research institutions and pharmaceutical companies MORE
249 The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. The 21st century has seen a massive change in the way people live their lives. It is now the digital era, and almost everything is online or made available in electronic form. There are now jobs online. MORE
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugsToday, as Congress kicks off hearings about the cost of prescription drugs in the United States, IQVIA published its 2019 report on The Global Use of Medicine in 2019 and Outlook to 2023. The top-line of the research is the robust pharma market growth will be driven by two factors, and limited by two others: spending in the U.S. MORE
Industry leaders across medtech and pharmaceutical sectors applaud proposal for its forward thinking MORE
179 
COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors. MORE
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients MORE
210 
Consumer experience Coronavirus COVID-19 Health and Beauty Health Consumers Health ecosystem Medication adherence Patient experience Pharmaceutical Pharmacy Prescription drugs Prevention Prevention and wellness Primary care Retail health Self-care Travel and health Wellness MORE
Consumer experience Coronavirus COVID-19 Employee benefits Health care industry Health Consumers Health costs Health ecosystem Health engagement Health insurance Healthcare access Medication adherence Medicines Mental health Oncology Patient engagement Pharmaceutical Pharmacy Physicians Prescription drugs Shopping and health Telehealth TelemedicineCOVID-19 is re-shaping health care in America across many dimensions. MORE
One in two people in the U.S. are concerned that a major health event in their family would lead to bankruptcy, up 5 percent points over the past eighteen months. MORE
Coronavirus COVID-19 Death Demographics and health Financial health Financial wellness Health citizenship Health Consumers Health costs Health disparities Health Economics Health equity Medicines Pharmaceutical Prescription drugs Race and health Social determinants of health MORE
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. Fewer American women, too, trust the healthcare industry than men do. MORE
Banks and health Beauty and health Consumer experience Design and health Grocery stores Health and Beauty Health care marketing Health Consumers Health costs Health ecosystem Health engagement Health marketing High deductibles Medical banking Medicines Money and health Patient experience Pharmaceutical Pharmacy Popular culture and health Prescription drugs Retail health Self-care Shopping and health Sleep Transparency Travel and health Trust User experience UX Wellbeing Wellness Workflow MORE
Connected health Consumer experience Consumer-directed health Financial health Financial wellness Health Consumers Health costs Health Economics Health engagement Health social networks High deductibles Patient engagement Patient experience Pharmaceutical Prescription drugs Social networks and health Specialty drugsConsider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied MORE
163 A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. In Healthcare 2030: The consumer at the center , the KPMG team explores the demographic shifts and market drivers that will challenge the health care industry in the current U.S. delivery and financing system. MORE
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. People in the U.S. MORE
The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs MORE
219 From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […]. MORE
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S. consumers age 18 and over in August and September 2019. These study respondents had also visited a doctor or hospital and paid a medical bill in the past year. MORE
As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. The article The Impact of Agile In The Pharmaceutical Industry appeared first on electronichealthreporter.com. MORE
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year MORE
182 
Pharmaceuticals Related Topics Electronic Health Reporter
OCTOBER 20, 2020
The article How Has Brexit Affected Pharmaceutical Distribution in the UK? Editorial Brexit pharmaceutical distribution UKThis article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.
Mobi Health News
AUGUST 5, 2020
The platform provides solutions in energy health and safety training and now brings its training expertise to the pharmaceuticals sector
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied
Electronic Health Reporter
AUGUST 28, 2018
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. The 21st century has seen a massive change in the way people live their lives. It is now the digital era, and almost everything is online or made available in electronic form. There are now jobs online.
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied
Mobi Health News
AUGUST 21, 2020
The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs
|
Electronic Health Reporter
AUGUST 3, 2020
From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […].
Mobi Health News
JULY 16, 2020
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year
Mobi Health News
JULY 15, 2019
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.
FierceHealthIT
SEPTEMBER 14, 2020
Industry Voices—Pharmaceutical supply chain adjustments to outlast COVID-19. hlandi. Mon, 09/14/2020 - 13:43
Mobi Health News
SEPTEMBER 10, 2020
Also: Skin Analytics' Series A contributes to AI-based detection of potential skin cancer; China's LickDoc supports its healthcare big data repository with $102 million
|
Digital Health
FEBRUARY 3, 2020
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin
Lloyd Price
NOVEMBER 26, 2018
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People The Chinese government estimates that spending in its healthcare sector will reach $2.3
Mobi Health News
AUGUST 20, 2020
The CARE consortium will accelerate R&D by bringing together expertise from research institutions and pharmaceutical companies
Health Populi
SEPTEMBER 9, 2020
One in two people in the U.S. are concerned that a major health event in their family would lead to bankruptcy, up 5 percent points over the past eighteen months.
Health Populi
SEPTEMBER 1, 2020
COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors.
Electronic Health Reporter
OCTOBER 25, 2018
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. Innovation is not a choice but rather a growth mindset, which creates an environment for building a sustainable business. This mindset allows for objectivity and contributions towards a bigger shared purpose.
FierceHealthIT
JUNE 22, 2018
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset
Health Populi
AUGUST 7, 2020
Consumer experience Coronavirus COVID-19 Health and Beauty Health Consumers Health ecosystem Medication adherence Patient experience Pharmaceutical Pharmacy Prescription drugs Prevention Prevention and wellness Primary care Retail health Self-care Travel and health Wellness
Health Populi
OCTOBER 8, 2019
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. How that demand side will reconcile with the supply side of pharmaceutical and life science companies, health insurers, retail pharmacy, hospitals and physicians — all strong and assertive lobbies inside the Beltway — will become clearer over the next thirteen months.
Health Populi
JULY 30, 2020
Coronavirus COVID-19 Death Demographics and health Financial health Financial wellness Health citizenship Health Consumers Health costs Health disparities Health Economics Health equity Medicines Pharmaceutical Prescription drugs Race and health Social determinants of health
Mobi Health News
AUGUST 3, 2020
Industry leaders across medtech and pharmaceutical sectors applaud proposal for its forward thinking
Health Populi
JULY 15, 2019
Banks and health Beauty and health Consumer experience Design and health Grocery stores Health and Beauty Health care marketing Health Consumers Health costs Health ecosystem Health engagement Health marketing High deductibles Medical banking Medicines Money and health Patient experience Pharmaceutical Pharmacy Popular culture and health Prescription drugs Retail health Self-care Shopping and health Sleep Transparency Travel and health Trust User experience UX Wellbeing Wellness Workflow
Health Populi
JULY 16, 2019
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. In Healthcare 2030: The consumer at the center , the KPMG team explores the demographic shifts and market drivers that will challenge the health care industry in the current U.S. delivery and financing system.
Health Populi
APRIL 17, 2019
Connected health Consumer experience Consumer-directed health Financial health Financial wellness Health Consumers Health costs Health Economics Health engagement Health social networks High deductibles Patient engagement Patient experience Pharmaceutical Prescription drugs Social networks and health Specialty drugsConsider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0.
Health Populi
OCTOBER 15, 2019
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S. consumers age 18 and over in August and September 2019. These study respondents had also visited a doctor or hospital and paid a medical bill in the past year.
Health Populi
JULY 11, 2019
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Artificial intelligence Big data and health Bio/life sciences Biotech Data analytics and health Health care industry Health ecosystem Health insurance Medicare Medicines Personalized medicine Pharmaceutical Venture capital and health
Health Populi
MAY 14, 2020
Consumer experience Coronavirus COVID-19 Employee benefits Health care industry Health Consumers Health costs Health ecosystem Health engagement Health insurance Healthcare access Medication adherence Medicines Mental health Oncology Patient engagement Pharmaceutical Pharmacy Physicians Prescription drugs Shopping and health Telehealth TelemedicineCOVID-19 is re-shaping health care in America across many dimensions.
Health Populi
JUNE 18, 2020
Bio/life sciences Financial toxicity Health Consumers Health costs Health policy Health politics media and health Medicaid Medicare Medicines Pharmaceutical Pharmacy Prescription drugs Retail health Specialty drugs Transparency Women and healthNine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today.
Mobi Health News
JUNE 23, 2019
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients
Health Populi
MARCH 29, 2019
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. citizens together is agreement that the cost of health care is too high in the country, and that pharma, health plans, and providers are to blame.
Health Populi
JUNE 9, 2020
Bio/life sciences Business and health Coronavirus COVID-19 Education and health Health benefits Health care industry Health citizenship Health Consumers Health costs Health ecosystem Health insurance Health Plans Health policy Health politics media and health Medical innovation Medicines Money and health Personal health finance Pharmaceutical Pre-existing conditions Prescription drugs Public health SDoH Shared decision making Social determinants of health Universal health care Wellbeing
Health Populi
OCTOBER 28, 2019
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. People in the U.S.
Health Populi
DECEMBER 2, 2019
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health. The driving forces shaping health and health care around the world are re-shaping health care financing and delivery around the world, and especially considering the growing role of patients in self-care — in terms of financing, clinical decision making and care-flows.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. In fact, if you knew that the business model of PLM was always to package and sell data to researchers, including the pharmaceutical industry, you may shrug your shoulders and assume there is no fundamental change. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen.
Health Populi
MAY 20, 2020
Chronic care Chronic disease Coronavirus COVID-19 Diabetes Digital health Health at home Health benefits Health care industry Health Consumers Health engagement Health finance Health insurance Health Plans Health policy Heart disease Home care Hospital finance Hospitals medical home Medicare Medication adherence Medicines Mental health Pharmaceutical Pharmacy Prescription drugs Prevention and wellness Primary care Self-care Telehealth Telemedicine Virtual healthPatients in the U.S.
Health Populi
APRIL 24, 2019
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. Fewer American women, too, trust the healthcare industry than men do.
Health Populi
JANUARY 29, 2019
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugsToday, as Congress kicks off hearings about the cost of prescription drugs in the United States, IQVIA published its 2019 report on The Global Use of Medicine in 2019 and Outlook to 2023. The top-line of the research is the robust pharma market growth will be driven by two factors, and limited by two others: spending in the U.S.
Health Populi
FEBRUARY 21, 2019
Behavior change Diabetes Employee benefits Employers Health benefits Health Consumers Health costs Health Economics Health engagement Health insurance Health politics Health reform Healthcare access Heart health HIV/AIDS Hospitals Loneliness Medicaid Medicare Medicines Money and health Personal health finance Pharmaceutical Prescription drugs Public health Seniors and health Social determinants of health Universal health careNational health spending in the U.S. is expected to grow by 5.7%
Health Populi
AUGUST 7, 2018
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.
Let's personalize your content